LINC01489

Across TCGA pan-cancer cohorts, LINC01489 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC01489 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher LINC01489 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC01489 expression acts as an unfavorable survival marker, although some lineages such as UCS and BRCA show a favorable association.

UCS, BRCA, and KICH are the cancer types where LINC01489 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Median	II,III,IV	0.593	0.124	<.001	90	view →
BRCA	OS	Tertile	III,IV	0.935	0.744	<.001	48	view →
KICH	OS	Tertile	III,IV	0.768	0.213	<.001	47	view →
ACC	DFS	Tertile	IV	0.487	0.091	.004	38	view →
READ	OS	Quartile	II,III,IV	0.776	0.964	<.001	37	view →
MESO	OS	Tertile	IV	0.639	0.171	.008	33	view →
DLBC	DFS	Median	II,III,IV	1.000	0.366	.015	24	view →
UVM	DFS	Tertile	All	0.210	0.761	.011	18	view →
LUAD	DFS	Quartile	III,IV	0.834	0.565	.004	18	view →
STAD	OS	Quartile	All	0.593	0.802	.012	16	view →
PCPG	OS	Median	All	1.000	0.728	.013	13	view →
KIRC	OS	Median	All	0.701	0.572	.007	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

LINC01489–UCS (DFS)

Open the UCS breakdown →